Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
35.53 USD | -2.31% | +0.03% | +31.35% |
Nov. 26 | Guardant Health Wins False Advertising Suit Against Natera | MT |
Nov. 07 | Top Premarket Gainers | MT |
Capitalization | 4.39B 4.18B 3.87B 3.44B 6.22B 373B 6.89B 48.22B 17.8B 153B 16.48B 16.13B 668B | P/E ratio 2024 * |
-10.4x | P/E ratio 2025 * | -11.7x |
---|---|---|---|---|---|
Enterprise value | 4.76B 4.53B 4.2B 3.74B 6.74B 404B 7.47B 52.3B 19.31B 166B 17.88B 17.49B 724B | EV / Sales 2024 * |
6.58x | EV / Sales 2025 * | 5.87x |
Free-Float |
-
| Yield 2024 * |
-
| Yield 2025 * | - |
Last Transcript: Guardant Health, Inc.
1 day | -2.31% | ||
1 week | +0.03% | ||
Current month | -0.22% | ||
1 month | +24.19% | ||
3 months | +49.47% | ||
6 months | +23.93% | ||
Current year | +31.35% |
Director | Title | Age | Since |
---|---|---|---|
Michael Wiley
DFI | Director of Finance/CFO | 48 | 2012-12-31 |
AmirAli Talasaz
CEO | Chief Executive Officer | 44 | 2021-08-04 |
Helmy Eltoukhy
CEO | Chief Executive Officer | 45 | 2012-12-31 |
Manager | Title | Age | Since |
---|---|---|---|
Helmy Eltoukhy
CHM | Chairman | 45 | 2021-08-04 |
AmirAli Talasaz
CHM | Chairman | 44 | 2012-12-31 |
Ian Clark
BRD | Director/Board Member | 63 | 2016-11-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.22% | 0 M€ | 0.00% | - | |
0.64% | 2 M€ | -.--% |
Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
---|---|---|---|---|---|---|
-2.31% | +0.03% | +38.03% | -62.31% | 4.49B | ||
-0.20% | +0.51% | +0.12% | -19.67% | 12.26B | ||
-0.29% | -0.51% | -9.44% | +49.07% | 7.44B | ||
-1.73% | +1.56% | +23.43% | +232.17% | 6.44B | ||
+0.24% | -0.86% | +15.19% | -41.60% | 5.85B | ||
+0.07% | -2.46% | -20.95% | -18.56% | 3.55B | ||
+0.42% | -2.04% | +14.97% | +120.15% | 2.7B | ||
+0.09% | -3.91% | +12.65% | -56.94% | 2.69B | ||
0.00% | -1.94% | -66.93% | -88.75% | 1.96B | ||
+0.34% | -1.52% | +21.90% | -37.20% | 1.84B | ||
Average | -0.34% | -0.02% | +2.90% | +7.64% | 4.92B | |
Weighted average by Cap. | -0.46% | +0.42% | +5.10% | +19.48% |
2024 * | 2025 * | |
---|---|---|
Net sales | 724M 689M 639M 568M 1.03B 61.44B 1.14B 7.95B 2.94B 25.23B 2.72B 2.66B 110B | 848M 807M 748M 665M 1.2B 71.93B 1.33B 9.31B 3.44B 29.53B 3.18B 3.11B 129B |
Net income | -415M -395M -366M -326M -588M -35.26B -652M -4.56B -1.68B -14.48B -1.56B -1.53B -63.18B | -377M -359M -333M -296M -534M -32.02B -592M -4.14B -1.53B -13.15B -1.42B -1.39B -57.38B |
Net Debt | 372M 354M 328M 292M 526M 31.54B 583M 4.08B 1.51B 12.95B 1.4B 1.37B 56.52B | 585M 557M 516M 459M 829M 49.65B 918M 6.43B 2.37B 20.39B 2.2B 2.15B 88.96B |
Date | Price | Change | Volume |
---|---|---|---|
24-12-10 | 35.53 $ | -2.31% | 1,328,916 |
24-12-09 | 36.37 $ | -1.36% | 1,109,014 |
24-12-06 | 36.87 $ | -0.65% | 1,567,821 |
24-12-05 | 37.11 $ | -2.62% | 1,496,005 |
24-12-04 | 38.11 $ | +6.51% | 2,198,051 |
Delayed Quote Nasdaq, December 10, 2024 at 04:00 pm EST
More quotesQuarterly revenue - Rate of surprise
- Stock Market
- Equities
- GH Stock